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PRACTICE
RECOMMENDATIONS
› Do not treat de Quervain’s
tenosynovitis with a corticosteroid injection plus a
nonsteroidal anti-inflammatory drug; the combination
is no more effective than
the injection alone. B
› Resection arthroplasty of
the carpometacarpal (CMC)
joint is the gold standard
for surgical treatment of
thumb CMC osteoarthritis,
but should be offered only if
conservative measures fail. C
› Percutaneous release of
trigger thumb combined with
a corticosteroid injection provides greater symptom relief
than the injection alone. C

A

mong the many possible causes of nontraumatic
thumb pain are 3 conditions that primary care physicians are likely to encounter again and again: de
Quervain’s tenosynovitis (dQT), first carpometacarpal osteoarthritis (CMC OA), and trigger thumb (TT). Common as they
are, however, there are no consensus guidelines for the treatment of these conditions.
With that in mind, we did a literature search for studies of
treatments for common causes of nontraumatic thumb pain.
After reviewing the findings, we developed this evidencebased summary—and the “bottom line” treatment guide on
page 331—as an aid to clinical decision making.
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de Quervain’s tenosynovitis: An overuse injury
dQT is characterized by a gradual onset of pain in the first
dorsal compartment of the wrist. The pain is reproduced on
physical exam with clenched fist ulnar deviation of the wrist
(Finkelstein test) (FIGURE ). The suspected cause is overuse,
leading to thickening of the tendons of the first dorsal compartment and subsequent resisted gliding of the tendons in
their fibro-osseous canal.1

Strength of recommendation (SOR)

A Good-quality patient-oriented
evidence
B Inconsistent or limited-quality
patient-oriented evidence
C Consensus, usual practice,
opinion, disease-oriented
evidence, case series

NSAIDs and injection: No better than injection alone
Conservative treatment of dQT consists of topical or oral
nonsteroidal anti-inflammatory drugs (NSAIDs), splinting,
and corticosteroid injection.1 We identified 2 studies using
such conservative modalities. The first was a randomized
double-blind, placebo-controlled trial, which found that oral
NSAIDs combined with corticosteroid injection provided no
statistically significant benefit compared with corticosteroid
injection alone (P=.69).2 The second study was a pooled qualitative analysis and showed that 83% (n=495) of patients were
asymptomatic after corticosteroid injection alone.3 Treatment failure in the remaining 17% of patients was attributed
to poor technique and anatomic variation within the first dorsal compartment.
C ON TIN U ED
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FIGURE

Finkelstein test for de Quervain’s tenosynovitis
B

PHOTOS COURTESY OF: STEPHANIE K. BUNT, PHD

A

With elbows flexed to 900, the forearms parallel to each other and the floor, and the thumb clenched gently inside a fist (A), the patient
drops the hand down (adduction) at the wrist (B). Pain over the first dorsal compartment is considered a positive test.

Another arm of the study compared the
combination of corticosteroid injection and
splinting with splinting alone, which yielded 61%
and 14% success rates, respectively. Some patients were treated with NSAIDs and rest alone,
but this intervention had a 0% success rate.3
Surgery has a high “cure rate”
Symptoms of dQT of >9 months’ duration
may not respond as well to conservative
therapy.4 In such cases—and for patients
for whom conservative measures bring only
short-term relief—a surgical referral may be
the best approach.
Surgery for dQT, a relatively simple
procedure in which the sheaths surrounding the inflamed tendons at the base of the
thumb are released to relieve the pain and
swelling, has uniformly positive results. The
“cure rate”—resolution of symptoms without complications—is reported to be >90%.1
One researcher found a positive correlation
between a longer duration (>9 months) of
preoperative symptoms and increased postoperative satisfaction (P<.4). 4

First carpometacarpal OA: Pain,
deformity, functional impairment
In a study of patients with joint-specific ar-
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thritis of the hand, the prevalence of first
CMC OA was reported at 21%.5 Symptoms
include pain and deformity that may result
in significant functional impairment of the
thumb. Physical findings may include pain
with palpation and swelling and warmth over
the dorsal aspect of the CMC joint. The “grind
test”—axial compression with internal and
external rotation of the CMC joint—should
reproduce the pain and may demonstrate
crepitus.6 As with osteoarthritis in general,
CMC OA radiographic findings do not directly correlate with the physical exam.
Splinting and physical therapy
bring considerable relief
Conservative treatment options for CMC OA
include NSAIDs, physical therapy, splinting,
and corticosteroid injection. American College of Rheumatology guidelines support
NSAIDs or acetaminophen as a first-line treatment for osteoarthritis pain of the knees and
hips, but no guidelines specifically address
CMC OA.7 Nor have there been any studies focused on NSAID therapy for CMC OA.
One retrospective study (n=130) evaluated splinting the thumb in abduction, and
found that it reduced symptoms of CMC
OA by an average of 54% to 61% at 6-month
follow-up.8 The researchers studied the re-
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Nontraumatic thumb pain:
A bottom line treatment guide
❚ de Quervain’s tenosynovitis. Initially, corticosteroid injection has been found to be the
most appropriate first-line treatment for dQT;1,4,5 the addition of an oral nonsteroidal antiinflammatory drug (NSAID) does not result in any additional benefit.5 What’s more, oral
NSAIDs and thumb splinting are not effective.3 Overall, surgical repair has demonstrated the
greatest success, but it is invasive and costly.1,4

❚ First carpometacarpal osteoarthritis. There are few valid clinical trials for CMC OA. The
available evidence, however, suggests starting with NSAIDs and progressing to splinting and
physical therapy, as needed. Corticosteroid injections provide no long-term pain relief.10,11 As
with osteoarthritis in general, surgery for CMC OA is usually reserved for patients who fail to
respond to conservative treatments.
❚ Trigger thumb. There are various methods and levels of success for trigger digit treatment,
but few studies specifically examining treatment of TT. The evidence suggests starting with
conservative treatment—corticosteroid injection and splinting—in patients who are opposed
to surgery.15 Both open and percutaneous surgical release of TT have high success rates, however, and can be offered at any time.13

sults of splinting in patients with stage 1 or
2 (mild to moderate) CMC OA vs those with
stage 3 or 4 (moderate to severe) CMC OA,
and found no significant difference in levels
of improvement. In another study of patients
with first CMC OA who were treated with
splinting and physical therapy for 7 months,
70% of those who underwent treatment declined subsequent surgery, suggesting symptom improvement.9
Corticosteroid injections alone for
CMC OA have had mixed results. One study
compared corticosteroid injection with saline
injection (n=40) and reported no difference
at 24 weeks’ posttreatment.10 Another found
short-term improvement from a corticosteroid
injection (n=25), as measured on a visual analog scale at 1 month (P<.001), but no significant
improvement in symptoms after 3 months.11
Consider surgery
if conservative measures fail
As with most cases of osteoarthritis, surgery
for CMC OA should be considered only after
failure of conservative treatment. Surgical
treatment options should be individualized,
depending on the extent of disease.
❚ Resection arthroplasty of the CMC
joint is the gold standard for surgical treatment of thumb CMC OA.6 In one small study
(n=24), researchers found that 90% of patients were satisfied with the outcome after
15 years.12 There are numerous surgical al-
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ternatives, however, and research addressing
resurfacing, synthetic implants, and spacer
materials is ongoing.6

Trigger thumb:
Swelling, pain, limited motion

Surgical repair
of de Quervain’s
tenosynovitis
has a “cure rate”
of >90%.

TT, also known as stenosing tenosynovitis, is characterized by swelling, limitation
of thumb range of motion, and a “catching”
sensation when the thumb is flexed. Pain is
usually referred to the first dorsal compartment of the hand. The primary pathology is
thickening of the A1 pulley, with resultant entrapment of the flexor tendon, thus forming a
triggering mechanism.13
Early treatment leads to better response
Conservative treatment options for TT include splinting and corticosteroid injection;
NSAIDs alone have not been found to provide any benefit.14 One study found that corticosteroid injection followed by splinting in
100 to 150 flexion for 3 to 12 weeks relieved
symptoms for 66% of those with any trigger
digit—but only 50% of patients with TT reported an improvement in symptoms.15
Overall, patients with TT symptoms for
<4 months have been found to respond significantly better to any treatment (P=.01).16
This finding may be related to repeat injury
to the tendon sheath, which leads to chronic
inflammation and permanent sheath hyper-
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Early diagnosis
and treatment
of trigger thumb
is important, as
repeat injury
leads to chronic
inflammation
and permanent
hypertrophy and
scarring of the
tendon sheath.

trophy and scarring,16 and highlights the importance of early diagnosis and treatment.
Limited research has been done on the
effect of corticosteroid injection alone on TT.
Maneerit et al performed a prospective study
(n=115) comparing steroid injection alone
with percutaneous release combined with
corticosteroid injection, and found that the
injection alone was successful in improving
symptoms in 47% of patients.17 (The combination of percutaneous release and steroid
injection, discussed below, had a much higher success rate.)
A retrospective study of treatment for
trigger digits demonstrated significant improvement with corticosteroid injection in
patients who did not have diabetes; 52% had
full resolution and 47% had improvement in
symptoms (P=.04).18 In contrast, corticosteroid injection led to symptom resolution for
only 32% of patients with diabetes.
Surgery for TT:
Percutaneous or open release
Surgical treatment options for TT include
percutaneous or open release. Complications
of surgical intervention for trigger digits include infection, digital nerve injury, scarring,
tenderness, and joint contractures. Nimigan

et al reported a 99% improvement in symptoms and return to activity with open surgical
release for patients with TT (n=72).18
In the study by Maneerit et al cited earlier, percutaneous release combined with
corticosteroid injection had a success rate
(indicated by decreased pain and triggering)
of 91%, vs a 47% response rate for the group
who received corticosteroid injection alone
(P=.001).17 In another study, 25 patients with
TT that had failed to respond to conservative
treatment underwent percutaneous release.
The result: An 84% success rate, as shown by
a decrease in reported pain on a visual analog
scale (P<.001), with no digital nerve damage
reported.13
Digital nerve damage is more of a concern with percutaneous release than with
open release, because of the proximity of the
digital nerves to the A1 pulley.13 Success rates
for percutaneous release vary from 38% to
100%, with improvement shown after approJFP
priate physician training.13
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